PARP3 and cancer: Additionally, while the selective inhibition of Parp3 emerges as a strong therapeutic option to target highly aggressive cancers, potential negative side effects onto physiological functions implicating differentiation events such as skeletal muscle integrity and/or regeneration as well as neuronal activity needs to be carefully considered.